Compare ClearPoint Neuro Inc (CLPT) vs TKO Group Holdings Inc (TKO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs TKO Group Holdings Inc — how do they compare? ClearPoint Neuro Inc trades at $15.22 (market cap $454.21M), while TKO Group Holdings Inc trades at $195.3 (market cap $14.24B). The key difference: TKO Group Holdings Inc is far larger — about 31.4× ClearPoint Neuro Inc's market cap, and TKO Group Holdings Inc pays a 1.6% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | TKO | |
|---|---|---|
Market Cap | $454.21M | $14.24B |
Sector | Health | Technology |
52-Week High | $29.60 | $224.96 |
52-Week Low | $8.66 | $176.49 |
Enterprise Value | $488.79M | $18.60B |
Dividend Yield | — | 1.6% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $15.20, up 4.32% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue growth but missed earnings estimates, with a net income margin of -81.76%. Recent news highlights regulatory progress with partners and expansion into focused ultrasound technology.
The outlook remains speculative with high growth potential in neurotherapy markets, but significant execution and profitability risks persist. Analyst consensus is unanimously bullish, though sustained losses and cash burn require careful monitoring for long-term investors.
TKO trades at $195.15, up 3.03% today, with a bullish technical outlook supported by moving averages and strong institutional sentiment. The stock shows robust revenue growth, with Q2 2026 revenue reaching $1.55 billion (up 18% year-over-year, Business Wire, August 3, 2026), and raised full-year guidance. However, a high P/E ratio of 68.33 and mixed quarterly EPS results highlight valuation concerns amid solid operational performance.
The outlook remains positive due to strong media rights and live event momentum, but risks include earnings volatility and competitive pressures. Analyst consensus is strongly bullish with a $228.17 price target, suggesting ~17% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About TKO Group Holdings Inc
TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →
